BG 777
Alternative Names: BG-777Latest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator Virocell
- Class Antiretrovirals
- Mechanism of Action Immunomodulators; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections; Coronavirus infections; Cytomegalovirus infections; HIV-1 infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Coronavirus-infections in Canada (IV)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Cytomegalovirus infections in Canada (IV-infusion)
- 16 Jul 2016 No recent reports of development identified for phase-I development in HIV-1-infections in Canada (IV-infusion)